DOES RECEPTION OF APPROPRIATE SHOCKS FROM THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AFFECT SURVIVAL

被引:13
作者
TCHOU, P
AXTELL, K
KEIM, S
ANDERSON, AJ
TROUP, P
JAZAYERI, M
AVITALL, B
AKHTAR, M
机构
[1] UNIV WISCONSIN,SINAI SAMARITAN MED CTR,MILWAUKEE,WI 53201
[2] UNIV PITTSBURGH,MED CTR,PITTSBURGH,PA 15260
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1991年 / 14卷 / 11期
关键词
SUDDEN DEATH; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SURVIVAL;
D O I
10.1111/j.1540-8159.1991.tb02792.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The implantable cardioverter defibrillator has become an important therapeutic modality for treatment of life-threatening ventricular tachyarrhythmias. Recent reports have suggested that patients who receive appropriate shocks from this device have an inordinately high overall mortality, and questioned the extent of benefit these patients derive from the implant. This report analyzed the survival among 184 patients who received the implantable cardioverter defibrillator to assess survival differences between patients who received appropriate shocks versus those who did not. At a mean follow-up of 24 +/- 18.7 months, 68 patients received an appropriate shock from their device while 116 did not receive an appropriate shock. Overall survival of the entire population was quite similar to those published by others. There was no significant difference between overall survival of patients who received an appropriate shock versus those who did not. However, there was a statistically significant difference in sudden death mortality. The group of patients that received appropriate shocks included all five sudden deaths. This observation suggested that sudden death in this population was likely due to ventricular tachyarrhythmias rather than strictly bradycardia or asystole. The "benefit" of the device to the entire population was also assessed by estimating survival after receipt of the first appropriate shock. Using this approach, an estimated 10% of patients died without receiving an appropriate shock. In other words, ultimately, 90% of patients were expected to benefit from the device. This survival curve, which initiated only after receipt of the first appropriate shock was fairly similar to those estimated from conventional methods. Therefore, survival after receipt of an appropriate shock was comparable to overall survival and there was no significant difference between survival of patients who received appropriate shocks and those who did not.
引用
收藏
页码:1929 / 1934
页数:6
相关论文
共 13 条
[1]   CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
ECHT, DS ;
ARMSTRONG, K ;
SCHMIDT, P ;
OYER, PE ;
STINSON, EB ;
WINKLE, RA .
CIRCULATION, 1985, 71 (02) :289-296
[2]   ACTUARIAL INCIDENCE AND PATTERN OF OCCURRENCE OF SHOCKS FOLLOWING IMPLANTATION OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
FOGOROS, RN ;
ELSON, JJ ;
BONNET, CA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (09) :1465-1473
[3]   AICD BENEFIT [J].
FURMAN, S .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (03) :399-400
[4]   AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - PATIENT SURVIVAL, BATTERY LONGEVITY AND SHOCK DELIVERY ANALYSIS [J].
GABRY, MD ;
BRODMAN, R ;
JOHNSTON, D ;
FRAME, R ;
KIM, SG ;
WASPE, LE ;
FISHER, JD ;
FURMAN, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (06) :1349-1356
[5]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[6]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS, AND DEVICE FAILURES [J].
MARCHLINSKI, FE ;
FLORES, BT ;
BUXTON, AE ;
HARGROVE, WC ;
ADDONIZIO, VP ;
STEPHENSON, LW ;
HARKEN, AH ;
DOHERTY, JU ;
GROGAN, EW ;
JOSEPHSON, ME .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) :481-488
[7]   MORTALITY IN PATIENTS WITH IMPLANTED AUTOMATIC DEFIBRILLATORS [J].
MIROWSKI, M ;
REID, PR ;
WINKLE, RA ;
MOWER, MM ;
WATKINS, L ;
STINSON, EB ;
GRIFFITH, LSC ;
KALLMAN, CH ;
WEISFELDT, ML .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) :585-588
[8]   THE AUTOMATIC IMPLANTABLE DEFIBRILLATOR [J].
MIROWSKI, M ;
MOWER, MM ;
REID, PR .
AMERICAN HEART JOURNAL, 1980, 100 (06) :1089-1092
[9]   AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND SURVIVAL OF PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AND MALIGNANT VENTRICULAR ARRHYTHMIAS [J].
TCHOU, PJ ;
KADRI, N ;
ANDERSON, J ;
CACERES, JA ;
JAZAYERI, M ;
AKHTAR, M .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (07) :529-534
[10]   THE MINIMALLY APPROPRIATE ELECTROPHYSIOLOGIC STUDY FOR THE INITIAL ASSESSMENT OF PATIENTS WITH DOCUMENTED SUSTAINED MONOMORPHIC VENTRICULAR-TACHYCARDIA [J].
WALDO, AL ;
AKHTAR, M ;
BRUGADA, P ;
HENTHORN, RW ;
SCHEINMAN, MM ;
WARD, DE ;
WELLENS, HJJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (05) :1174-1177